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Background & aims: Lutein and zeaxanthin accumulate in retina (macular pigment). Their nutritional status can be
assessed using dietary or biochemical markers and both have been associated with macular pigment optical
density. We proposed to assess dietary and status markers of lutein and zeaxanthin in a group of healthy Spanish
volunteers, considering the potential influence of age, gender and serum lipids to investigate the predictors of the
macular pigment optical density.
Methods: Serum lutein and zeaxanthin concentrations, dietary intake and macular pigment optical density were
determined in 108 healthy men and women (20–35 and 45–65 years), using high-performance liquid chromatography,
3-day food records and heterochromic flicker photometry, respectively. Mann–Whitney U-test, Spearman correlation
coefficient and multivariate regression analysis were used for the statistical study.
Results: Serum concentrations and dietary intake of lutein plus zeaxanthin (p < 0.0001 and p = 0.001, respectively) were
higher in older vs younger subjects, whereas macular pigment optical density was lower (p = 0.038). The highest
correlation coefficients between intake and serum were for fruit and serum lutein (ρ = 0.452, p < 0.0001) and for fruit
and lutein + zeaxanthin (ρ = 0.431, p < 0.0001) in the younger group. Macular pigment optical density correlated with
serum xanthophylls (ρ = 0.223, p = 0.02) and fruit and vegetable intake (ρ = 0.350, p = 0.0002), showing highest
correlations when lutein and zeaxanthin were expressed in relation to serum lipids in older subjects (ρ = 0.262, p = 0.006).
Multivariate regression analysis identified age and serum lutein as major predictors of macular pigment optical density
(total sample), and a coefficient of determination of 29.7% for the model including lutein + zeaxathin/cholesterol +
triglycerides, sex and fruit + vegetables in the older group.
Conclusions: The establishment of normal/reference ranges for serum lutein and zeaxanthin should consider age ranges
and be expressed in relation to lipid concentrations, at least in subjects over 45 years, as this could influence macular
pigment optical density. The macular pigment optical density showed age-specific correlations with lutein plus zeaxanthin
expressed in relation to serum lipid concentrations as well as with the fruit and vegetable intake.
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Lutein and zeaxanthin are plant pigments that belong to
the well-known group of carotenoids, subgroup of xantho-
phylls (oxycarotenoids), found in the human body (blood,
tissues, and concentrated in retina, where they constitute
what it is known as the macular pigment [MP]). They are
provided only in the diet, and are transported in blood to
the different tissues by lipoproteins [1]. Both xanthophylls,
but primarily lutein, have been investigated in relation to
eye health and disease. They act by filtering blue-light and
as antioxidants that may protect macular pigment from
oxidative damage induced by light and the high rate of
oxidative metabolism in the eye. Moreover, there is in-
creasing evidence suggesting that MP may protect against
age-related maculopathy [2].
Traditionally, exposure to or nutritional status assess-
ment of lutein (generally assessed together with zeaxan-
thin) in human subjects has routinely been performed
using dietary or biochemical methods [2-5]. The dietary in-
take of lutein and its presence in blood / tissues (i.e. in ret-
ina) have been associated with a lower risk for age-related
diseases, and the levels increase upon the ingestion of
lutein-rich foods and lutein supplements [3,6,7]. Determin-
ation of serum lutein and zeaxanthin concentrations has
been considered the best available method for establishing
their nutritional status in human subjects [2,4,5], and these
concentrations are affected by dietary and host-related fac-
tors that influence their absorption and utilization [3,7].
The lutein concentration in serum is considered to reflect
short-term dietary intake and, although it often correlates
poorly with said intake, it is widely accepted as a good
biomarker of fruit and vegetable intake [3].
The MP density can be considered a marker of long-
term dietary exposure [4,8] that can be measured by a
number of techniques and the most widely used noninva-
sive test is heterochromatic flicker photometry [9]. Its as-
sessment is increasingly being performed due to new
commercially available devices that can easily be employed
in clinical practice. To know to what extent macular
pigment optical density (MPOD) can be considered a sur-
rogate measure of lutein and zeaxanthin intake and status,
we need more data from well-defined, homogeneous popu-
lations, with information on the many factors affecting the
levels of these compounds. This would shed light on their
role in visual function and in the reduction of risk of eye
diseases, and allow comparisons between population
groups. Dietary and serum lutein and zeaxanthin concen-
trations have often been positively associated with MP
[5,7,8], but conflicting results have been reported concern-
ing the influence of several variables (sex [2,9], age [2],
body mass index (BMI) [10] and lipids [11]), among other
factors.
This study was designed to assess: 1) dietary and status
markers (diet, serum and MPOD) of lutein and zeaxanthin,together with serum lipid profile as a confounding factor
and, 2) the predictive value of those compounds and
several confounding factors (age, sex, serum lipids) for the
MPOD, in a population of well-characterized healthy
Spanish volunteers, grouped according to age and gender,
as these factors can modify the lutein and zeaxanthin con-
centrations in the three status markers or the correlations
among them.Materials and methods
Subjects and study design
108 volunteers (54 men and 54 women), divided into
two age groups (20 to 35 y and 45 to 65 y) (mean ± SD:
25.6 ± 3.2 y and 52.4 ± 5.2 y, respectively) were enrolled
in a cross-sectional study. These age groups were estab-
lished because of their different dietary habits and risk
of age-related ocular disease. Participants were selected
from those subjects who were interested and contacted
through advertisements in different universities, research
centers, and several noticeboards (i.e. intranet of several
Spanish ministries). Of the 137 individuals who showed
their interest in participating in the study, 5 were excluded
because of a high cholesterol level, 4 because they were
taking omega-3 food supplements or enriched milk, 2
because of his/her BMI and 19 because their age and sex
corresponded to a group in which the established number
of subjects had been reached. The inclusion criteria were
normal cholesterolemia, BMI under 30 kg/m2, mixed diet
(no avoidance of any food groups). Volunteers were asked
to report information on the following exclusion criteria:
consumption of dietary supplements, BMI under 20 kg/m2,
surgery for myopia (within the previous year), cataracts or
macular degeneration, use of drugs or phytosterol-enriched
beverages/foods to control cholesterol level, regular con-
sumption of n-3 fatty acid-enriched food products and
chronic diseases that can affect carotenoid or lipid metabol-
ism (i.e. diabetes, cardiovascular disease).
The volunteers included in this cross-sectional study
underwent blood sampling, assessment of the MPOD and
3-day food records. The subjects were enrolled over the
course of an entire year (during the spring and summer:
40 in the younger and 29 in the older age group, and, dur-
ing the fall and winter: 14 in the younger and 25 in the
older age group). Blood samples were collected after over-
night fast (at least 8 hours) and serum obtained for the
analysis of lutein, zeaxanthin and lipid profile.
This study was conducted in accordance with the
guidelines laid down in the Declaration of Helsinki and
all procedures involving human subjects were approved
by the Clinical Research Ethics Committee of Hospital
Universitario Puerta de Hierro-Majadahonda of Madrid,
Spain (registry no. 257, dated 19 July 2010). Written in-
formed consent was obtained from all subjects.
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Lutein and zeaxanthin levels were determined by high
performance liquid chromatography (HPLC) using a sys-
tem consisting of a model 600 pump, a Rheodyne injector
and a 2998 photodiode array (PDA) detector (Waters,
Milford, MA, USA) in accordance with standard proce-
dures described elsewhere [12]. We used a Spheri-5 ODS
5 μm (220 mm× 4.6 mm) chromatographic column
(Brownlee Labs, Applied Biosystem, Santa Clara, CA,
USA) with a guard column (Aquapore ODS type RP-18).
The mobile phase was acetonitrile-methanol (85:15; v/v),
and was changed to acetonitrile-dichloromethane-
methanol (70:20:10; v/v/v) in a linear gradient from min 5
to min 20. Both mobile phases were stabilized with
ammonium acetate (0.025 mol L−1) added to the metha-
nol. The flow rate was 1.8 mL min−1, and detection was
performed at a wavelength of 450 nm. All chromatograms
were processed using Empower 2 software (Waters, Milford,
MA, USA).
Carotenoid extraction was performed on serum samples
using a slight modification of a previously published
method [12]. Briefly, 200 μl of serum was added to 200 μl
of ethanol, vortexed and extracted twice with 400 μl of
hexane: dichloromethane (5:1) stabilized with 0.1 g/L bu-
tylated hydroxyltoluene. Organic phases were pooled,
evaporated to dryness under nitrogen atmosphere and
reconstituted with 200 μl of a solution of tetrahydrofuran:
ethanol (1:2) and injected (5 μl) onto the HPLC system.
Methanol, ethanol, acetonitrile, dichloromethane, am-
monium acetate, butylated hydroxytoluene (BHT) and
tetrahydrofuran were supplied by Panreac (Barcelona,
Spain). Lutein (xanthophyll from marigold) was obtained
from Sigma Chemical Co. (St. Louis, MO, USA) and
zeaxanthin was purchased from Fluka Analytica (Sigma
Aldrich).
Standard solutions were prepared from 1 mg of lutein
and of zeaxanthin dissolved in 25 mL tetrahydrofuran,
with 0.01% BHT in each case. The E1cm
1% values and
wavelengths used were as follows: lutein, 2550 at
445 nm; zeaxanthin, 2540 at 450 nm. Working solutions
were obtained from different volumes of the standard
solutions dissolved in tetrahydrofuran: ethanol (1:2 v/v).
The concentrations of the carotenoids in the curve were:
0.27-1.36 μg mL−1 for lutein (R2 = 0.999) and 0.03-
0.15 μg mL−1 for zeaxanthin (R2 = 0.999).
Blood total cholesterol and high-density lipoprotein
(HDL) cholesterol were analyzed by colorimetric enzyme
assay (Cobas Integra 400 plus, Roche). The low-density
lipoprotein (LDL) cholesterol level was calculated with
the Friedewald al equation [13]. Serum triglycerides
were determined using an enzymatic colorimetric test
(Roche Diagnostics, GmbH Manheim, Germany), a
method that employs lipase, glycerol kinase, glycerol-3-
phosphate oxidase and peroxidase.Dietary intake assessment
Recent dietary intake was evaluated using 3-day food re-
cords involving 24 h recalls, one of which coincided with
a weekend or holiday, carried out within a period of 7 to
10 days. For the first recall, the participants underwent a
face-to-face encounter with a specialized interviewer,
normally the same person who, subsequently, performed
the other two recalls by telephone. The amounts con-
sumed were estimated in units (fruits), portions or
household servings standardized for this study [14]. On
the basis of this information, we calculated food intake
in grams/day, which served as the basis for the deter-
mination of the daily lutein and zeaxanthin intake using
a database designed by our group, included in a software
application for the calculation of dietary intake of indi-
vidual carotenoids [15]. To evaluate the lipid and energy
intake, we employed a food composition table widely
used in Spain [14].
Macular pigment optical density (MPOD) assessment
Macular pigment optical density was assessed using an
MPS 9000 desktop device (Macular Pigment Screener,
Elektron PLC, Cambridge, UK) that applies the principles
of heterochromatic flicker photometry. The technique and
reliability of this device are described in detail by van der
Veen et al. [16]. The test consists of two stages for central
and peripheral viewing, and the subjects were required to
press a response button as soon as they detect flicker. The
subjects started by fixating the central stimulus, a 1-
degree central target (flicker rate is initially set to 60 Hz
and then gradually reduced at a rate of 6 Hz s−1). The
process was repeated for a series of green-blue luminance
ratios. The observer then fixated a red 2°-diameter target
placed 8° eccentrically and a second set of data were
recorded for peripheral viewing [17]. The MPOD is mea-
sured in density units (du) and ranges from 0 to 1.
Statistics
Sample size calculation was performed on the basis of a
mean value for MPOD of 0.40 du. A sample of 108 sub-
jects (SD = 0.10) was found to be necessary to obtain a
10% difference in the MPOD (0.04 du) with 85% power
and an alpha error of 0.05. Data are expressed as the mean
and standard deviation, median and 95% confidence inter-
val. The normal distribution of the data was assessed
(Kolmogorov-Smirnov test) and, as lutein and zeaxanthin
in serum and diet and serum triglycerides did not follow a
normal distribution, the Mann–Whitney U test was used
to compare concentrations of the variables analyzed in the
two groups (established according to sex and age). Age and
sex were introduced as covariates in the generalized linear
model and only age affected the concentration/intake of
several variables. No interactions were observed for any of
the variables except for serum lutein + zeaxanthin/HDL
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cholesterol which was influenced by sex.
Correlations among variables in serum, diet and the
MPOD were established using Spearman’s rho correlation
coefficient. All reported P-values are based on a two-sided
test and compared to a significance level of 5%.
Multiple linear regression analysis was carried out using
backward elimination as a model selection procedure, with
macular pigment optical density as dependent variable and
the following independent variables: sex, age, lutein and ze-
axanthin in serum and in diet, lutein + zeaxanthin in serum
and in diet, lutein + zeaxanthin/cholesterol + triglycerides,
lutein + zeaxanthin/HDL-cholesterol, lutein + zeaxanthin/
LDL-cholesterol and fruit and vegetable consumption.
SPSS v.20 (SPSS Inc., Chicago, IL, USA) software was used
for all statistical calculations.Results
Table 1 shows the concentration of lutein and zeaxanthin
in diet and serum, serum lipids, energy intake, MPOD and
BMI of the sample as a whole and grouped according to
age and sex, expressed as the mean and standard devi-
ation, median and confidence interval. While there were
no differences in lutein and zeaxanthin in serum and diet
when the sexes were compared, we did observe differences
between the two age groups, with higher concentrations
in the older subjects than in the younger subjects. The lu-
tein concentration was higher than the zeaxanthin con-
centration in both dietary intake (10.8-fold) and serum
(4.6-fold) in the total sample (median values).
The difference in lutein and zeaxanthin between the two
age groups disappeared when their concentrations were
expressed in relation to serum lipids (cholesterol + triglyc-
erides), but was maintained when intake was expressed in
terms of dietary energy density (lutein plus zeaxanthin/
1000 kcal). Regarding lipids in serum (all the subjects had
serum cholesterol levels within normal range), the total
cholesterol and LDL-cholesterol concentrations showed
age-related differences (higher in older vs younger sub-
jects), whereas HDL-cholesterol and triglyceride concen-
trations showed sex-related differences (the former higher
in women than in men and the latter vice versa). The
mean BMI in the total sample was within normal range
(23.4 ± 2.7 kg/m2), being higher in men vs women and in
older vs younger subjects (p = 0.002). Finally, there were
differences in the MPOD related to age (lower in older vs
younger individuals, p = 0.038) but not to sex.
The dietary intake of the major sources of lutein and ze-
axanthin (fruit, vegetables and eggs) is shown in Table 2.
Energy intake was significantly greater in men than in
women (p < 0.001), but this was not the case with the in-
take of food sources of lutein and zeaxanthin, which only
show age-related differences (with the exception of eggconsumption), as they were consumed in greater amounts
in the older group.Correlations between diet and serum concentrations of
lutein and zeaxanthin and their major food sources
The concentrations of lutein and zeaxanthin in diet, as
well as the amounts of fruit and vegetables consumed,
correlated significantly with the concentrations of lutein
and zeaxanthin in serum in the total sample (Table 3).
On comparing the age groups, those correlations were
observed in the younger group but not in the older
group (except for zeaxanthin and fruit and vegetable
consumption). The intake of lutein and zeaxanthin,
expressed as concentration per 1000 kcal, correlated sig-
nificantly with their concentrations in serum in the total
sample, a finding that was due to their correlations in
the younger subjects. The highest correlation coefficients
were for the correlations between fruit intake and lutein
and lutein plus zeaxanthin concentrations in serum (ρ =
0.452, p < 0.0001 and ρ = 0.431, p < 0.0001, respectively)
in the younger group.
Egg consumption, a good source of lutein, is lower
than the Spanish mean intake (32 g/day) [18], showed a
wide variability and had a significant inverse correlation
with the serum lutein and zeaxanthin concentrations in
the older group. The degree of correlation loses statis-
tical significance if only those individuals who consumed
eggs are assessed.Correlations of lutein and zeaxanthin in diet and serum
and the major sources of their dietary intake with
macular pigment optical density
As shown in Table 4, the MPOD did not correlate signifi-
cantly with serum lutein or zeaxanthin in the total sample,
but showed significant correlations when they were
expressed in relation to cholesterol plus triglycerides (ρ =
0.170, p = 0.012) and to serum LDL cholesterol concentra-
tions (ρ = 0.162, p = 0.017). However, in the older group,
in addition to the aforementioned relationships, we ob-
served correlations with lutein, zeaxanthin (ρ = 0.223, p =
0.02) and with lutein plus zeaxanthin when expressed in
relation to HDL-cholesterol (ρ = 0.272, p = 0.004) and
LDL-cholesterol (ρ = 0.301, p = 0.002). There were no
such significant correlations in the younger group.
With respect to the relationship between MPOD and
the dietary intake of lutein and zeaxanthin, there were no
correlations except for that of zeaxanthin in the older sub-
jects and an inverse correlation with the lutein density in
the total sample and in the younger group. However, there
were significant correlations between fruit and vegetable
intake and the MPOD in the older subjects, showing the
highest coefficient correlations for the intake of fruit plus
vegetables (ρ = 0.350, p = 0.0002), as well as in the total
Table 1 Dietary intake and serum concentrations of lutein and zeaxanthin, macular pigment optical density, serum
lipids and body mass index in Spanish subjects (n=108) expressed as mean ± standard deviation, (median) and
confidence interval [95% CI]
Men Women Aged 20–35 years Aged 45–65 years Total sample
(n = 54) (n = 54) (n = 54) (n = 54) (n = 108)
Concentrations in serum
Lutein (μg/dl) 13.0 ± 6.9 12.7 ± 5.5 10.9 ± 5.0b 14.8 ± 6.6b 12.8 ± 6.2
(11.2) (11.7) (10.0) (13.0) (11.6)
[11.1; 14.8] [11.2; 14.2] [9.5; 12.3] [13.0; 16.6] [11.7; 14.0]
Zeaxanthin (μg/dl) 2.9 ± 1.4 2.8 ± 1.3 2.7 ± 1.2 3.0 ± 1.5 2.8 ± 1.4
(2.6) (2.5) (2.4) (2.6) (2.6)
[2.5; 3.2] [2.5 ; 3.2] [2.4; 3.0] [2.6; 3.4] [2.6; 3.1]
Lutein + zeaxanthin (μg/dl) 16.5 ± 8.1 15.6 ± 6.6 14.3 ± 6.5b 17.9 ± 7.8b 16.1 ± 7.4
(14.6) (14.1) (12.8) (15.7 ) (14.4)
[14.3; 18.8] [13.8; 17.5] [12.5; 16.1] [15.7; 20.0] [14.7; 17.5]
Lutein + zeaxanthin/cholesterol + triglycerides
(μg/mg)
0.06 ± 0.03 0.06 ± 0.03 0.06 ± 0.03 0.06 ± 0.03 0.06 ± 0.03
(0.05) (0.06) (0.05) (0.05) (0.05)
[0.05; 0.06] [0.06; 0.07] [0.05; 0.07] [0.05; 0.07] [0.06; 0.07]
Cholesterol (mg/dl) 186.0 ± 42.9 187.1 ± 42.9 165.4 ± 43.2b 207.7 ± 43.1b 186.6 ± 48.0
(178) (191) (163.5) (201.0) (188)
[174.3; 195.7] [172.7; 2016] [153.6; 177.2] [196.0; 219.5] [177.4; 195.7]
HDL cholesterol (mg/dl) 52.5 ± 14.1a 62.4 ± 12.8a 55.6 ± 12.9 59.4 ± 15.5 57.5 ± 14.3
(51.5) (65.5) (54) (60.0) (56)
[48.7; 56.4] [58.9; 65.9] [52.1; 59.1] [55.1; 63.6] [54.8; 60.2]
LDL cholesterol (mg/dl) 110.7 ± 37.2 109.7 ± 43.6 92.8 ± 35.3b 127.6 ± 37.7b 110.2 ± 40.3
(107) (112.5) (88 ) (121.5) (108)
[100.6; 120.9] [97.8; 121.5] [83.1; 102.4] [117.3; 137.9] [102.5; 117.9]
Triglycerides (mg/dl) 105.7 ± 55.3a 74.5 ± 23.9a 86.3 ± 36.3 94.0 ± 52.7 90.1 ± 45.2
(87.9) (70.5) (76.0 ) (78.5) (78)
[90.6; 120.8] [68.0; 81.1] [76.4; 96.2] [79.6; 108.4] [81.5; 98.8]
Dietary intake
Lutein (μg/day) 955.4 ± 1418.1 1190.8 ± 1727.4 903.9 ± 1571.8b 1242.3 ± 1579.3b 1073.1 ± 1577.4
(408.8) (410.5) (339.2) (528.8) (410.5)
[568.4; 1342.5] [719.3; 1662.3] [474.9; 1333.0] [811.3; 1673.4] [772.2; 1374.0]
Zeaxanthin (μg/day) 78.6 ± 121.1 111.7 ± 155.7 91.5 ± 143.5 98.8 ± 137.2 95.2 ± 139.8
(31.8) (48.9) (33.0) (46.3) (38.1)
[45.6; 111.7] [69.2; 154.2] [52.3; 130.7] [61.3; 136.2] [68.5; 121.8]
Lutein + zeaxanthin (μg/day) 1052.8 ± 1531.6 1283.7 ± 1860.6 995.4 ± 1705.0b 1341.1 ± 1693.1b 1168.3 ± 1700.0
(445.9) (452.5) (369.0) (678.6) (451.0)
[634.8; 1470.9] [775.9; 1791.5] [530.0; 1460.8] [879.0; 1803.2] [844.0; 1492.5]
Lutein + zeaxanthin/1000 Kcal (μg/day) 47.5 ± 71.2 66.8 ± 91.5 47.7 ± 78.4b 66.6 ± 85.4b 57.1 ± 82.2
(21.2) (26.0) (18.8) (31.9) (23.8)
[2.5; 323.9] [3.5; 379.0] [2.4; 367.5] [4.3; 335.3] [2.56; 329.4]
Macular pigment optical density (density units)
MPOD (n = 216 eyes) 0.352 ± 0.150 0.342 ± 0.155 0.370 ± 0.140b 0.325 ± 0.158b 0.347 ± 0.108
(0.360) (0.350) (0.360) (0.320) (0.360)
[0.323; 0.382] [0.311; 0.373] [0.341; 0.398] [0.293; 0.356] [0.326; 0.370]
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Table 1 Dietary intake and serum concentrations of lutein and zeaxanthin, macular pigment optical density, serum
lipids and body mass index in Spanish subjects (n=108) expressed as mean ± standard deviation, (median) and
confidence interval [95% CI] (Continued)
Body mass index (kg/m2) 24.9 ± 2.2a 21.8 ± 2.4a 22.7 ± 2.8b 24.0 ± 2.5b 23.4 ± 2.7
(25.0) (21.5) (22.6) (24.1) (23.0)
[24.3; 25.4] [21.2; 22.5] [22.0; 23.5] [23.3; 24.7] [22.8; 23.9]
Serum values are expressed as mean ± standard deviation (each datum is the mean of three replicate injections), (median) and confidence interval [95% CI].
a Significant difference between sexes (p < 0.0001).
b Significant difference between age groups (p < 0.0005 for all variables, except for BMI p = 0.002).
HDL: high-density lipoprotein; LDL: low density lipoprotein; MPOD: macular pigment optical density.
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tions were found in the younger group (Figure 1).
The MPOD showed age-specific correlations with lutein
plus zeaxanthin expressed in relation to serum lipid con-
centrations as well as with the fruit and vegetable intake.
Multivariate regression analysis of dietary and
biochemical factors associated with the MPOD
Table 5 corresponds to the regression model used to
evaluate the predictive value of age, sex, lutein and zea-
xanthin in diet and serum, also expressed in relation to
serum lipids, cholesterol (total, HDL- and LDL-), triglyc-
erides and fruit and vegetable intakes on the MPOD
value. The table shows only results that do not include
zero in the confidence interval. In the total sample, age
and serum lutein were the main predictors of MPOD.
The R2 in the total sample was 11.2% (predictive vari-
ables: grams of fruit, age, lutein + zeaxanthin/HDL and
serum lutein). However, upon analysis of the sample ofTable 2 Dietary intake of the major sources of lutein and zea
mean ± standard deviation, (median) and confidence interva
Men Women Aged
Food groups (g/day)
Fruit 225.4 ± 197.4 223.4 ± 178.6 15
(200.0) (193.9)
[171.5; 279.3] [174.6; 272.1] [1
Vegetables 280.8 ± 158.1 269.1 ± 140.1 23
(261.2) (271.4)
[237.6; 323.9] [246.6; 303.3] [2
Fruit + vegetables 506.2 ± 278.2 492.5 ± 265.6 38
(451.0) (475.5)
[430.3; 582.1] [420.0; 565.0] [3
Eggs 25.8 ± 28.5 24.8 ± 21.8 2
(21.3) (21.3)
[18.1; 33.6] [18.8; 30.7] [
Energy intake (Kcal) 2334 ± 584a 1895 ± 402a 2
(2233) (1904)
[2174; 2493] [1785; 2004] [1
aSignificant difference between sexes (p < 0.001).
bSignificant difference between age groups (p < 0.001).older subjects, the main predictor was the concentration
of lutein plus zeaxanthin in serum related to the concen-
tration of lipids (cholesterol plus triglycerides) and, to a
lesser extent, sex (in this group, the men had higher
MPOD than the women). The R2 in the older subjects
was 29.7% (predictive variables: sex, fruit in grams, vege-
tables in grams and lutein + zeaxanthin/cholesterol +
triglycerides).
Discussion
Lutein status is routinely assessed together with zeaxan-
thin, using dietary or biochemical methods, both of
which have advantages and limitations, although serum
concentration has been considered the best method for
establishing their nutritional status in humans [3]. Dif-
ferent factors linked either to the subject or to diet can
influence their concentrations in serum and their bio-
availability [3,7,10]. For this report, we selected a sample
of apparently healthy subjects with similar serum lipids,xanthin intake (g/day) and energy intake expressed as
l [95% CI]
20–35 years Aged 45–65 years Total sample (n = 108)
0.4 ± 119.5b 298.4 ± 213.1b 224.4 ± 187.3
(151.9) (269.2) (197.5)
17.8; 183.0] [240.2; 356.6] [188.7; 260.1]
8.0 ± 128.4b 311.9 ± 159.4b 275.0 ± 148.8
(231.0) (290.7) (266.3)
02.9; 273.0] [268.4; 355.4] [246.6; 303.3]
8.4 ± 190.2b 610.3 ± 294.6b 499.3 ± 270.8
(410.3) (577.3) (458.7)
36.4; 440.3] [529.9; 690.7] [447.7; 551.0]
5.7 ± 24.8 24.9 ± 26.0 25.3 ± 25.3
(21.3) (20.7) (21.3)
18.9; 32.4] [17.8; 32.0] [20.5; 30.1]
096 ± 494 2133 ± 597 2114 ± 546
( 2072) (1994) (2054)
961; 2231] [1970; 2296] [2010; 2218]
Table 3 Correlations (Spearman’s ρ and (p value)) between lutein, zeaxanthin and major food sources for dietary
intake and serum concentrations
Serum Aged 20 – 35 years Aged 45 – 65 years Total sample
Dietary intake Lutein Zeaxanthin Lutein +
Zeaxanthin
Lutein Zeaxanthin Lutein +
Zeaxanthin
Lutein Zeaxanthin Lutein +
Zeaxanthin
Lutein 0.266
(0.052)
0.250
(0.068)
0.274
(0.045)
0.135
(0.332)
0.200
(0.148)
0.160
(0.247)
0.250
(0.009)
0.228
(0.018)
0.257
(0.007)
Zeaxanthin 0.296
(0.030)
0.205
(0.136)
0.324
(0.017)
0.156
(0.258)
0.366
(0.007)
0.238
( 0.083)
0.221
(0.022)
0.313
(0.001)
0.286
(0.003)
Lutein + zeaxanthin 0.313
(0.021)
0.281
(0.040)
0.314
(0.021)
0.145
(0.296)
0.227
(0.098)
0.173
(0.212)
0.256
(0.007)
0.212
(0.027)
0.277
(0.004)
Lutein + zeaxanthin
(density)
0.312
(0.022)
0.286
(0.036)
0.316
(0.020)
0.072
(0.606)
0.201
(0.145)
0.119
(0.390)
0.211
(0.029)
0.195
(0.043)
0.239
(0.013)
Fruit 0.452
(0.001)
0.400
(0.003)
0.431
(0.001)
0.154
(0.266)
0.340
(0.012)
0.219
(0.111)
0.381
(0.000)
0.382
(0.000)
0.382
(0.000)
Vegetables 0.243
(0.076)
0.205
(0.138)
0.225
(0.101)
0.102
(0.463)
0.199
(0.149)
0.122
(0.379)
0.215
(0.025)
0.214
(0.026)
0.200
(0.038)
Fruit and vegetables 0.447
(0.001)
0.399
(0.003)
0.401
(0.003)
0.125
(0.368)
0.317
(0.020)
0.181
(0.189)
0.355
(0.000)
0.353
(0.000)
0.341
(0.000)
Eggs 0.055
(0.693)
−0.001
(0.996)
0.096
(0.492)
−0.293
(0.033)
−0.342
(0.012)
−0.327
(0.017)
−0.122
(0.210)
−0.193
(0.047)
−0.124
(0.203)
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http://www.nutritionj.com/content/13/1/52body weight and dietary habits (varied diet and no dietary
supplements) from two different age groups having the
same proportion of men and women. To our knowledge,
this is the first study to simultaneously assess dietary and
status markers of lutein and zeaxanthin (diet, serum andTable 4 Statistically significant correlations (Spearman’s ρ an
sources for their intake in serum and diet with MPOD (two ey
Serum
Lutein
Zeaxanthin
Lutein + zeaxanthin
Lutein + zeaxanthin/cholesterol + triglycerides
Lutein/cholesterol + triglycerides
Zeaxanthin/cholesterol + triglycerides
Lutein/HDL cholesterol
Zeaxanthin/HDL cholesterol
Lutein + zeaxanthin/HDL-cholesterol
Lutein + zeaxanthin/LDL-cholesterol
Cholesterol
Dietary intake
Zeaxanthin
Lutein (density)
Fruit
Vegetables
Fruit and vegetables
MPOD: macular pigment optical density; HDL: high-density lipoprotein; LDL: low deMPOD) in Spanish subjects taking into account several
confounding factors.
Serum lutein and zeaxanthin concentrations are similar
to those reported in other groups of Spanish subjects [12]
and somewhat lower than [4,10] or similar to [1,19,20]d (p value)) between lutein, zeaxanthin and major food
es/subject, n=216)
MPOD
Aged 45 – 65 years Total sample
0.204 (0.034)
0.267 (0.005)
0.223 (0.020)
0.262 (0.006) 0.170 (0.012)
0.258 (0.007) 0.176 (0.009)
0.298 (0.002) 0.152 (0.025)
0.239 (0.013)
0.282 (0.003)
0.272 (0.004)
0.301 (0.002) 0.162 (0.017)
−0.227 (0.018)
0.230 (0.017)
−0.147 (0.030)
0.318 (0.001) 0.160 (0.018)
0.255 (0.008)
0.350 (0.000) 0.171 (0.012)
nsity lipoprotein.
Figure 1 Correlation between MPOD (du) and fruit and vegetable intake (g) in the younger (circle and dotted line) (r2 = 0.001) and older
(square and solid line) (r2 = 0.188) groups.
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http://www.nutritionj.com/content/13/1/52those of comparable age in several European and North
American countries. Serum lutein concentrations in the
present study, and in practically all those mentioned
above, are much lower than the >34 μg/dL (0.6 μmol/L)
that seem to be consistently associated with lower risk in
epidemiological studies (including lower risk for age-
related macular degeneration and cataracts) and higher
MPOD [3].
We observed no sex differences in serum concentrations
and dietary intake of lutein and zeaxanthin or in MPOD,
findings reported in a number of studies [4,20-22], al-
though other authors observed higher intake in women
[23]. In contrast, although cholesterol was within normal
range, there were differences in serum lipids, and higher
triglyceride and lower HDL-cholesterol levels were ob-
served in men. However, serum lutein and zeaxanthin
concentrations differed according to the age group, being
higher in the older subjects. Their intake, both crude andTable 5 Multivariate regression analysis of biochemical and d
β (SE)
Total sample
Constant 0.413 (0
Age - 0.094
Lutein (serum) 0.008 (0
Older group (45–65 y)
Constant 0.246 (0
Sex - 0.086
Lutein + zeaxanthin/cholesterol + triglycerides 1.165 (0
MPOD: macular pigment optical density; SD: standard deviation; CI: confidence inteenergy-adjusted, is also greater, as reported elsewhere [24],
and this group consumes more fruits and vegetables, as
well. These differences disappear when serum concentra-
tions are related to levels of circulating lipids (lutein + zea-
xanthin/cholesterol + triglycerides), transporters of these
xanthophylls, which are being considered for a better in-
terpretation of the antioxidant/nutritional status [11,25]
or are expressed as 1000 kcal intake. The MPOD in the
total sample was 0.35 du, similar to that of other studies
[21,22,26], and differed according to age [17].
However, the amount of lutein plus zeaxanthin intake
(median value) is much lower than that found by our
group more than a decade ago in European subjects (n =
400) [27]. In that study, the intake in the Spanish subgroup
(n = 80) was 3.25 mg/day (range: 1.8-4.3 mg/d), which con-
trasts with the 0.45 mg/d of this study, which, in turn, is
similar to the mean intake in the Spanish population ob-
tained in national surveys (0.5 mg and 0.1 mg/person/dayietary factors, sex and age data associated with MPOD
p 95% CI
.036) 0.000 0.342, 0.485
(0.023) 0.000 - 0.139, −0.048
.003) 0.013 0.002, 0.014
.058) 0.000 0.131, 0.361
(0.027) 0.002 - 0.139, −0.032
.491) 0.020 0.191, 2.140
rval.
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http://www.nutritionj.com/content/13/1/52of lutein and zeaxanthin, respectively) [28]. It is also similar
to the levels reported in other populations [10]. If we com-
pare the mean intake usually found in the literature, rather
than the median value (preferable since the data usually do
not follow a normal distribution), the mean intake of
1.2 mg is similar or slightly below the range described in
other studies [6,8,21,24].
The different intake levels found in the literature are
largely attributable to the differences among databases
for carotenoid composition in foods and the types of
dietary questionnaires employed [12]. Regarding the
aforementioned European study, the food composition
data utilized are very similar to those used in this report
[15] since, in both cases, much of the data resulted from
HPLC analysis of Spanish foods; however, the European
study was based on a semiquantitative food frequency
questionnaire (FFQ), whereas in the present study, 3-day
food records were employed. FFQ have been reported to
overestimate carotenoid intake [23], especially that of
lutein and zeaxanthin when comparing these two
methods [12]. FFQ were used in those studies in which
intake concentrations were higher and 2 or 3-day recalls
were employed in others in which the concentrations
were comparable. On the other hand, the data from
population-based studies in the USA and Spain indicate
that levels of lutein and zeaxanthin intake have declined,
particularly from dark-green leafy vegetables [29]. An-
other aspect to be considered regarding lutein intake is
food seasonality; however, in the Spanish population, the
mean intake of lutein has been reported to be relatively
constant throughout the year [28].
Concerning the sex differences in lutein and zeaxanthin
intake, the results in the literature are inconsistent, indicat-
ing a higher intake among women [22,23], in whom a
lower energy intake [23] or no differences [21] are likewise
reported. There are also discrepancies in the findings ac-
cording to age group, with some studies that show no dif-
ferences [4] and others that do; in the later, as in our study,
a higher intake is reported for older individuals [24].
Lutein intake is higher than that of zeaxanthin in all
populations [6,20]; in a typical western diet, a ratio of 7:1
(lutein:zeaxanthin) has been reported [8]. This is lower
than that found in our study, which is 11:1 in the total
sample and 13:1 in the older subjects, who consume more
fruit and vegetables (Table 2) than the younger partici-
pants (10:1). The mean intake of fruits and vegetables is
higher than that recommended by the WHO to decrease
risk of chronic diseases (400 g/day).
The degree of correlation between lutein and zeaxanthin
concentrations in serum and diet is significant, being
higher if determined by dietary intake of fruit and vegeta-
bles, rather than by measuring the concentrations of these
xanthophylls as provided by the diet (Table 3). The
Pearson correlation coefficient between their serumconcentrations and dietary intake is >0.2 and is >0.3 when
serum concentrations correlate with food consumed, as in
other studies [8,21,22,26]. Aside from the amount injested,
the degrees of correlation between biological markers, ap-
parently low, are influenced by many other subject-related
factors (i.e. sex, age, BMI, eating habits, sample size), as
well as metabolic factors [2,8], and in our study, the
degrees of correlation were found to vary according to age
group, but not sex. Thus, in younger subjects, there is a
correlation between serum levels and dietary intake (in
terms of both the concentrations of these compounds
intake density) whereas, in older subjects correlation was
observed only for zeaxanthin, despite the fact that these
individuals have higher levels both in their intake and in
serum. Therefore, other metabolic factors must influence
metabolism of these xanthophylls, such as the uptake of
lutein and zeaxanthin from plasma and their transport to
the retina (e.g. serum lipid levels, or binding protein in
optical tissue with binding capacity for zeaxanthin iso-
mers, but not for lutein) [7]. Correlation in young subjects
but not in their elders has been reported by other authors
[19]. However, the correlations between serum concentra-
tions and fruit and vegetable intake are significant in both
age groups, especially for fruit intake.
The concentration of lutein and zeaxanthin in the retina,
assessed by MPOD, was lower in the older subjects, despite
the fact that their intake was higher than that of younger
individuals (also expressed in relation to 1000 kcal). These
higher intakes are reflected in the higher serum concentra-
tions, although the differences disappear when the levels
are expressed in relation to serum lipids. Correlations be-
tween MPOD and serum lutein and zeaxanthin and dietary
intake reached the highest significance level for zeaxanthin
and for lutein + zeaxanthin in relation to lipids (cholesterol
+ triglycerides, LDL-cholesterol and HDL-cholesterol) and
when related to diet (lutein density and fruits and vegeta-
bles) (Table 4). Lutein and zeaxanthin are transported in
LDL and HDL in similar amounts and it is widely accepted
that oxidative modifications of LDL and HDL affect lipo-
protein metabolism and modified LDL may have an effect
on retinal pigment epithelial cells [30].
There are significant correlations in the elderly group,
but not in the younger group (except the correlation
with the lutein intake expressed as concentration per
1000 kcal, [ρ = −0.214, p = 0.026]). Although, MPOD is
often positively associated with dietary and serum lutein
and zeaxanthin concentrations [26], conflicting results
have been reported on the influence of sex [22], age [8],
BMI [2,31], and other postprandial or environmental fac-
tors (e.g. smoking) [22]. The highest correlations between
MPOD and lutein and zeaxanthin in serum and dietary in-
take correspond to fruit and vegetables (ρ = 0.35) and to
lutein + zeaxanthin/HDL-cholesterol (ρ = 0.301); the latter
is consistent with the identification of HDL as the specific
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http://www.nutritionj.com/content/13/1/52transporter of lutein and zeaxanthin to retina in chicks
[32]. The strong correlation between MPOD and fruit and
vegetable intake, also reported elsewhere [26], indicates
that not only the amounts of lutein and zeaxanthin are
important for ocular tissue; there are other micronutrients
and bioactive compounds in these foods that are also
beneficial (e.g. fiber and polyunsaturated fatty acid intake
are also directly related to MPOD) [33]. On the other
hand, few studies have assessed lutein and zeaxanthin
status simultaneously using the three possible markers
(diet, serum and MPOD) and these studies are not very
homogeneous in terms of factors that can exert an influ-
ence such as sex, age, serum lipids and BMI, among others
[21,22,26]. Nevertheless, although consistent associations
among these three markers have not always been found,
most studies point to the protective role of a diet rich in
fruits and vegetables. However, in multivariate regression
analysis, performed to assess the predictive value of lutein
and zeaxanthin concentrations in serum and dietary
intake, sex, age and the concentrations of different serum
lipids for MPOD, only the serum lutein concentration and
lutein + zeaxanthin in relation to cholesterol + triglycer-
ides, but not fruit and vegetable intake, correlate with
MPOD. Moreover, age is an important predictor in the
total sample, as is sex in the older group, although we
observed no sex differences in the MPOD values in this
study, a fact that could be explained if the availability of
lutein and zeaxanthin to the retina could be influenced by
physiological sex differences [22] (i.e. if binding protein in
optical tissue specific for zeaxanthin responds differently
in men and women [7]).
Conclusions
In conclusion, lutein and zeaxanthin concentrations in
serum and dietary intake of these xanthophylls and of
their major food sources are higher in older vs younger
subjects; however, MPOD is lower. In younger individuals,
MPOD is influenced by serum lutein but, in older individ-
uals, the presence of lutein plus zeaxanthin in relation to
circulating lipids is a determining factor. Thus, when
establishing normal/reference ranges for serum lutein and
zeaxanthin, age ranges should be taken into account and
the levels of these xanthophylls should be expressed in
relation to the lipid concentration, at least in subjects over
45 years of age, as this could influence MPOD.
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